BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 29939941)

  • 1. Generation and characterization of an
    Li R; Ying B; Liu Y; Spencer JF; Miao J; Tollefson AE; Brien JD; Wang Y; Wold WSM; Wang Z; Toth K
    Dis Model Mech; 2020 Aug; 13(8):. PubMed ID: 32651192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of knockout rabbits with X-linked severe combined immunodeficiency (X-SCID) using CRISPR/Cas9.
    Hashikawa Y; Hayashi R; Tajima M; Okubo T; Azuma S; Kuwamura M; Takai N; Osada Y; Kunihiro Y; Mashimo T; Nishida K
    Sci Rep; 2020 Jun; 10(1):9957. PubMed ID: 32561775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease.
    Blanco E; Izotova N; Booth C; Thrasher AJ
    Front Immunol; 2020; 11():608653. PubMed ID: 33329605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive B Cell Loss in Revertant X-SCID.
    Lin CH; Kuehn HS; Thauland TJ; Lee CM; De Ravin SS; Malech HL; Keyes TJ; Jager A; Davis KL; Garcia-Lloret MI; Rosenzweig SD; Butte MJ
    J Clin Immunol; 2020 Oct; 40(7):1001-1009. PubMed ID: 32681206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic Genetic Reversion of a Duplication Event in IL2RG in Siblings.
    Cruz PD; Rylaarsdam S; Torgerson TR; Hagin D; Allenspach EJ
    J Clin Immunol; 2023 Nov; 43(8):1747-1750. PubMed ID: 37481508
    [No Abstract]   [Full Text] [Related]  

  • 6. T
    Stepensky P; Keller B; Shamriz O; von Spee-Mayer C; Friedmann D; Shadur B; Unger S; Fuchs S; NaserEddin A; Rumman N; Amro S; Molho Pessach V; Abuzaitoun O; Somech R; Elpeleg O; Ehl S; Warnatz K
    J Clin Immunol; 2018 May; 38(4):527-536. PubMed ID: 29948574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Immunodeficiencies Unravel the Role of IL-2/CD25/STAT5b in Human Natural Killer Cell Maturation.
    Caldirola MS; Rodríguez Broggi MG; Gaillard MI; Bezrodnik L; Zwirner NW
    Front Immunol; 2018; 9():1429. PubMed ID: 29988287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening using TREC/KREC assay for severe T and B cell lymphopenia in Iran.
    Nourizadeh M; Shakerian L; Borte S; Fazlollahi M; Badalzadeh M; Houshmand M; Alizadeh Z; Dalili H; Rashidi-Nezhad A; Kazemnejad A; Moin M; Hammarström L; Pourpak Z
    Scand J Immunol; 2018 Aug; 88(2):e12699. PubMed ID: 29943473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synonymous splice site mutation in IL2RG gene causes late-onset combined immunodeficiency.
    Yamashita M; Wakatsuki R; Kato T; Okano T; Yamanishi S; Mayumi N; Tanaka M; Ogura Y; Kanegane H; Nonoyama S; Imai K; Morio T
    Int J Hematol; 2019 May; 109(5):603-611. PubMed ID: 30850927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated Signaling.
    Tuovinen EA; Pöysti S; Hamdan F; Le KM; Keskitalo S; Turunen T; Minier L; Mamia N; Heiskanen K; Varjosalo M; Cerullo V; Kere J; Seppänen MRJ; Hänninen A; Grönholm J
    J Clin Immunol; 2023 Feb; 43(2):358-370. PubMed ID: 36260239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of mutatio-type on proteo-phenotype and clinico-phenotype in selected primary immunodeficiencies.
    Halacli SO
    Immunol Res; 2022 Feb; 70(1):56-66. PubMed ID: 34622368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel IL2RG Mutation Causes Leaky TLOWB+NK+ SCID With Nodular Regenerative Hyperplasia and Normal IL-15 STAT5 Phosphorylation.
    Neves JF; Martins C; Cordeiro AI; Neves C; Plagnol V; Curtis J; Fabre M; Bibi S; Borrego LM; Moshous D; Nejentsev S; Gilmour K
    J Pediatr Hematol Oncol; 2019 May; 41(4):328-333. PubMed ID: 29939941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IL-2RG R328X nonsense mutation allows partial STAT-5 phosphorylation and defines a critical region involved in the leaky-SCID phenotype.
    Arcas-García A; Garcia-Prat M; Magallón-Lorenz M; Martín-Nalda A; Drechsel O; Ossowski S; Alonso L; Rivière JG; Soler-Palacín P; Colobran R; Sayós J; Martínez-Gallo M; Franco-Jarava C
    Clin Exp Immunol; 2020 Apr; 200(1):61-72. PubMed ID: 31799703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Hemizygous IL2RG p.(Pro58Ser) Mutation Impairs IL-2 Receptor Complex Expression on Lymphocytes Causing X-Linked Combined Immunodeficiency.
    Tuovinen EA; Grönholm J; Öhman T; Pöysti S; Toivonen R; Kreutzman A; Heiskanen K; Trotta L; Toiviainen-Salo S; Routes JM; Verbsky J; Mustjoki S; Saarela J; Kere J; Varjosalo M; Hänninen A; Seppänen MRJ
    J Clin Immunol; 2020 Apr; 40(3):503-514. PubMed ID: 32072341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel common gamma chain mutation in a Chinese family with X-linked severe combined immunodeficiency (X-SCID; T(-)NK(-)B(+)).
    Tan W; Yu S; Lei J; Wu B; Wu C
    Immunogenetics; 2015 Nov; 67(11-12):629-39. PubMed ID: 26409833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy.
    Pike-Overzet K; van der Burg M; Wagemaker G; van Dongen JJ; Staal FJ
    Mol Ther; 2007 Nov; 15(11):1910-6. PubMed ID: 17726455
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.